Previous Article | Next Article ![]()
Journal of Clinical Microbiology, October 2001, p. 3724-3726, Vol. 39, No. 10
Institute for Medical Microbiology and
Virology1 and Institute of Pharmacology
and Clinical Pharmacology,3 Heinrich-Heine
University Düsseldorf, Düsseldorf, Germany, and
Eijkman-Winkler Institute for Medical Microbiology,
University Medical Center Utrecht, Utrecht, The
Netherlands2
Received 28 December 2000/Returned for modification 31 May
2001/Accepted 18 July 2001
The prevalence of integrons in five enterobacterial species was
analyzed in 900 blood culture isolates from 1993, 1996, and 1999. Remarkably, the prevalence increased from 4.7% in 1993 to 9.7% in
1996 and finally to 17.4% in 1999 (P < 0.01).
Within 7 years the combined percentage of P1 strong promoters and P1
weak plus P2 active promoters with high transcription efficacies
has increased from 23.1 to 33.3 and finally 60% (P < 0.05).
Integrons are genetic structures
capable of integrating or mobilizing individual gene cassettes encoding
antibiotic resistance determinants (1, 3-6, 9, 12, 16).
Previous studies have demonstrated that these integron structures occur
widely among Enterobacteriaceae in European hospitals and
are associated with resistance to multiple classes of antibacterial
compounds (4, 7, 10, 11, 14, 15).
Integrons possess two essential elements located at the 5'-conserved
segment (CS) that are able to mobilize and insert gene cassettes,
namely, an int gene encoding a site-specific recombinase belonging to the integrase family and its associated primary
recombination site, attI (3-6). While four
types of integrons, each with different int genes, have been
identified to date, most integrons found in clinical enterobacterial
isolates are class I integrons. With few exceptions, the gene cassettes
in an integron are expressed from a common promoter region located in
the 5'-CS of the integron. The promoter region contains two potential
promoters called P1 and P2. Four different P1 promoters (a strong, a
weak, and two hybrid promoters) and two different P2 promoters (an
active and an inactive form) have been described (2, 3,
8). The strengths of the different promoters have been assessed
relative to that of the depressed Escherichia coli tac
promoter (3). The strong version of the P1 promoter is six
times more effective than the tac promoter, but the
tac promoter is more efficient than the weak and hybrid P1
promoters. The weak P1 and active P2 promoters, acting together,
initiate transcription three times more efficiently than the
tac promoter (3).
In this study we aimed to analyze potential changes in the prevalence
of integrons in five enterobacterial species and to investigate
alterations in promoter structure and gene cassette size over a period
of 7 years. Therefore, we screened 900 enterobacterial isolates
from blood cultures obtained from patients treated at the University
Hospital Düsseldorf in 1993, 1996, and 1999. For each year the
first 200 isolates of E. coli and the first 25 isolates of
each of the species Klebsiella pneumoniae, Klebsiella
oxytoca, Enterobacter aerogenes, and Enterobacter
cloacae were analyzed for the presence of class I integrons and
the size of the inserted DNA, which gives some indication of the number
of inserted genes. We also sequenced the 5'-CS promoter regions of the
isolates positive for integrons. The numbers of isolates for the
different species reflect the frequency of isolation. Statistical
comparisons were performed with Fisher's exact test for proportions,
and a Bonferroni-Holm correction was applied to the significance level
in cases of multiple comparisons.
Random amplified polymorphic DNA (RAPD) typing of all 300 isolates from
each of the three years was used as a rapid screening method to exclude
potential clonally identical isolates (10, 13). Of the 300 isolates tested in each of the years 1993, 1996, and 1999, 276, 278, and 287 different RAPD types were distinguished, respectively. Only
those isolates considered unrelated were analyzed further in the study.
PCR procedures with various primers to detect the integron structures
and to sequence the 5'-CS promoter region have been described
previously (10, 11, 15). Primers 5'-CS and 3'-CS were used
to identify the presence of an integron and to determine the size of
any inserted gene cassette. In addition, primer
Int2F, specific for the 3' region of the
integrase gene (approximately 600 bp upstream from the 5'-CS primer
site), was used in combination with primer 3'-CS to show the proximity
of inserted gene cassettes to intI (10).
Two additional primers were specific for the 16S rRNA gene and were
used as positive PCR controls ensuring the integrity of all sample DNA
used to detect integrons (10). Furthermore, the presence
of integron structures as well as of resistance genes in the cassettes
of integrons was confirmed by sequencing the PCR products and the
contents of the gene cassettes of half of those isolates carrying
integron structures, as described previously (11).
Among the 900 isolates tested, 841 different RAPD types were
distinguished, of which 90 (16.6%) were shown to carry integron structures. Remarkably, the prevalence of integrons has increased significantly from 13 of 276 (4.7%) in 1993 to 27 of 278 (9.7%) in
1996 and finally to 50 of 287 (17.4%) in 1999 (P < 0.01) (Table 1).
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.10.3724-3726.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Increased Prevalence of Class I Integrons in
Escherichia coli, Klebsiella Species, and
Enterobacter Species Isolates over a 7-Year Period
in a German University Hospital
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
TABLE 1.
Percentage of integron-positive isolates and sizes of
inserted gene cassettes for five different enterobacterial species
in 1993, 1996, and 1999
K. oxytoca was the species with the highest proportion of integron-positive isolates (20 of 65 [26.8%]). In addition, 6.3% of the E. coli isolates (3 of 585), 10.6% (7 of 66) of the K. pneumoniae isolates, 21.9% (14 of 64) of the E. cloacae isolates, and 19.7% (12 of 61) of the E. aerogenes isolates were integron positive (Table 1).
With respect to inserted gene cassettes, sizes of 650 to 1,800 bp were detectable in 1993; by 1999 the cassette sizes had increased to 750 to 3,000 bp. The range of inserted gene cassette sizes detected over the study period varied between 650 bp (found in E. coli) and 3,000 bp (in isolates of E. coli, K. oxytoca, and K. pneumoniae). In all species tested, multiple insert sizes were recorded, demonstrating the heterogeneity of inserted sequence sizes. In general, larger inserted gene cassette sizes were detected in 1999. The 3,000-bp inserted gene cassette was detected in E. coli, K. pneumoniae, and K. oxytoca isolates from Düsseldorf in 1999 for the first time, while the smallest inserted gene cassette of 650 bp could be detected only in E. coli isolates from 1993.
By use of the primer sets described previously (10), seven isolates (four E. coli, one K. oxytoca, one K. pneumoniae, and one E. aerogenes isolate) were found to possess "empty" integron structures with no inserted gene cassettes. All these isolates originated from 1993; this phenomenon was no longer observed in 1996 and 1999. Thus, increases in integron prevalence and in the sizes of inserted gene cassettes were observed in parallel over the 7 years of the study period.
The different sizes of the gene cassettes inserted between the CS regions of the strains studied demonstrate the variable nature of these structures, presumably reflecting differences in the number and type of inserted gene cassettes. Additionally, many inserted regions of DNA, indistinguishable with respect to size, were detected in isolates from different species or in isolates of the same species shown to be unrelated by genotyping, which is suggestive of horizontal transfer. Recent studies have suggested that intra- or interspecific transfer of the entire integron, presumably via plasmids or transposons, is a more frequent event than single-gene mobilization or integration via the integrase (11). However, these studies do not preclude the possibility that other class I integrons harbor more mobile inserted gene cassette combinations.
In addition, the structures of the promoter regions of the integron-positive isolates were analyzed, and a shift in the distribution of different promoters was observed. In 1993, of 13 integron-positive isolates, 8 had P1 weak promoters, 2 had P1 strong promoters, 2 had P1 hybrid promoters, and 1 had a P1 weak promoter plus a P2 active promoter. In 1996 this distribution had changed: of 27 integron-positive isolates, 15 had P1 weak promoters, 6 had P1 strong promoters, 3 had P1 hybrid promoters, and 3 had P1 weak plus P2 active promoters. Finally, in 1999, the following distribution of promoters among the 50 integron-positive isolates could be detected: 17 P1 weak, 23 P1 strong, 3 P1 hybrid, and 7 P1weak plus P2 active. Within 7 years the percentage of promoters with high transcription efficacies, i.e., P1 strong promoters and P1 weak plus P2 active promoters, had increased significantly, from 23.1% (3 of 13) in 1993 to 33.3% (9 of 27) in 1996 and 60% (30 of 50) in 1999 (P < 0.05). These data suggest that the genes adjacent to the promoter region were potentially expressed with a higher efficiency in 1999 than in 1993, although besides promoter variety, the plasmid copy number and the presence of other internal promoters may also affect expression.
Compared with the 751 integron-negative isolates, the 90 integron-positive isolates were statistically more often resistant to
some
-lactam compounds, e.g., ampicillin (53 versus 37%)
(P < 0.01), ticarcillin (49 versus 29%)
(P < 0.01), piperacillin (42 versus 19%)
(P < 0.01), and trimethoprim-sulfamethoxazole (52 versus 7%) (P < 0.01)). This association between
integron carriage and decreased susceptibility to certain antibiotics
is in line with the findings of previous investigations (10,
15).
While 82% of the integron-positive isolates originated from intensive care units, 10% came from non-intensive-care-unit wards and 8% came from outpatients. The decreased susceptibility or the resistance to antibiotics provided by integrons and their association with other episomal elements also involved in antimicrobial resistance can explain their widespread occurrence in the nosocomial environment with constant or increasing antibiotic pressure. The increased prevalence of integrons observed in a university hospital offers cause for concern and may indirectly assist in our understanding of the dynamics and molecular basis of multidrug resistance in gram-negative bacteria.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Institute for Medical Microbiology and Virology, Heinrich-Heine-University Düsseldorf, Universitätsstraße 1, Geb. 22.21, D-40225 Düsseldorf, Germany. Phone and fax: 0049-2132-72040. E-mail: schmitfj{at}uni-duesseldorf.de.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Brown, H. J.,
H. W. Stokes, and R. M. Hall.
1996.
The integrons In0, In2, and In5 are defective transposon derivatives.
J. Bacteriol.
178:4429-4437 |
| 2. | Bunny, K. L., R. M. Hall, and H. W. Stokes. 1995. New mobile gene cassettes containing an aminoglycoside resistance gene, aacA7, and a chloramphenicol resistance gene, catB3, in an integron in pBWH301. Antimicrob. Agents Chemother. 39:686-693[Abstract]. |
| 3. | Collis, C. M., and R. M. Hall. 1995. Expression of antibiotic resistance genes in the integrated cassettes of integrons. Antimicrob. Agents Chemother. 39:155-162[Abstract]. |
| 4. | Fluit, A. C., and F. J. Schmitz. 1999. Class 1 integrons, gene cassettes, mobility, and epidemiology. Eur. J. Clin. Microbiol. Infect. Dis. 18:761-770[CrossRef][Medline]. |
| 5. | Hall, R. M., D. E. Brookes, and H. W. Stokes. 1991. Site-specific insertion of genes into integrons: role of the 59-base element and determination of the recombination cross-over point. Mol. Microbiol. 5:1941-1959[Medline]. |
| 6. | Hall, R. M., and C. M. Collis. 1995. Mobile gene cassettes and integrons: capture and spread of genes by site-specific recombination. Mol. Microbiol. 15:593-600[CrossRef][Medline]. |
| 7. | Jones, M. E., E. Peters, A. M. Weersink, A. Fluit, and J. Verhoef. 1997. Widespread occurrence of integrons causing multiple antibiotic resistance in bacteria. Lancet 349:1742-1743[Medline]. |
| 8. | Levesque, C., S. Brassard, J. Lapointe, and P. H. Roy. 1994. Diversity and relative strength of tandem promoters for the antibiotic resistance genes of several integrons. Gene 142:49-54[CrossRef][Medline]. |
| 9. | Levesque, C., L. Piche, C. Larose, and P. H. Roy. 1995. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob. Agents Chemother. 39:185-191[Abstract]. |
| 10. |
Martinez-Freijo, P.,
A. C. Fluit,
F. J. Schmitz,
V. S. Grek,
J. Verhoef, and M. E. Jones.
1998.
Class I integrons in Gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds.
J. Antimicrob. Chemother.
42:689-696 |
| 11. |
Martinez-Freijo, P.,
A. C. Fluit,
F. J. Schmitz,
J. Verhoef, and M. E. Jones.
1999.
Many class I integrons comprise distinct stable structures occurring in different species of Enterobacteriaceae isolated from widespread geographic regions in Europe.
Antimicrob. Agents Chemother.
43:686-689 |
| 12. |
Recchia, G. D., and R. M. Hall.
1995.
Gene cassettes: a new class of mobile element.
Microbiology
141:3015-3027 |
| 13. | Renders, N., U. Römling, H. Verbrugh, and A. van Belkum. 1996. Comparative typing of Pseudomonas aeruginosa by random amplification of polymorphic DNA or pulsed-field gel electrophoresis of DNA macrorestriction fragments. J. Clin. Microbiol. 34:3190-3195[Abstract]. |
| 14. | Sallen, B., A. Rajoharison, S. Desvarenne, and C. Mabilat. 1995. Molecular epidemiology of integron-associated antibiotic resistance genes in clinical isolates of Enterobacteriaceae. Microb. Drug Resist. 1:195-202[Medline]. |
| 15. | Schmitz, F. J., P. Martinez-Freijo, S. Theis, A. C. Fluit, J. Verhoef, H. P. Heinz, and M. E. Jones. 1999. Prevalence of class I integrons and association with decreased antibiotic susceptibility in German gram negative blood culture isolates. Clin. Microbiol. Infect. 5:496-498[Medline]. |
| 16. | Stokes, H. W., and R. M. Hall. 1989. A novel family of potentially mobile DNA elements encoding site-specific gene-integration functions: integrons. Mol. Microbiol. 3:1669-1683[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»